Cargando…
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Colorectal cancer (CRC) is the third most diagnosed malignancy and a major leading cause of cancer-related deaths worldwide. Despite advances in therapeutic regimens, the number of patients presenting with metastatic CRC (mCRC) is increasing due to resistance to therapy, conferred by a small populat...
Autores principales: | Al Bitar, Samar, El-Sabban, Marwan, Doughan, Samer, Abou-Kheir, Wassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044855/ https://www.ncbi.nlm.nih.gov/pubmed/36998426 http://dx.doi.org/10.3748/wjg.v29.i9.1395 |
Ejemplares similares
-
Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models
por: Al Bitar, Samar, et al.
Publicado: (2022) -
Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional in vitro models
por: Monzer, Alissar, et al.
Publicado: (2022) -
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
por: Yehya, Amani, et al.
Publicado: (2022) -
Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins
por: Shahait, Mohammed, et al.
Publicado: (2018) -
The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
por: Azar, Joseph, et al.
Publicado: (2021)